JAGSONPAL PHARMACEUTICALS
|
The Current P/E Ratio of JAGSONPAL PHARMACEUTICALS is 25.76.
Share Price | ₹235.3 | Aug 22,2025 |
Market Cap | ₹1,567.1 Cr | |
Earnings-TTM | ₹60.8 Cr | TTM-Standalone Results |
Price/Earnings | 25.76x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of JAGSONPAL PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,567.1 Cr] as on Aug 22,2025
(/) Earnings [ ₹60.8 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 25.76x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay 25.76 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JAGSONPAL PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JAGSONPAL PHARMACEUTICALS
PE Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 24.59x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 28.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 43.57x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 5.81x.
How does JAGSONPAL PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
JAGSONPAL PHARMACEUTICALS | 60.83 | 25.76 | 1,567.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.86 | 394,187.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 70.81 | 163,282.0 |
CIPLA LTD | 5,406.81 | 23.79 | 128,619.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 62.29 | 124,712.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.61 | 106,577.0 |
MANKIND PHARMA LTD | 1,905.51 | 56.45 | 107,559.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.45 | 99,496.4 |
LUPIN LTD | 3,722.18 | 24.24 | 90,234.1 |
AUROBINDO PHARMA LTD | 3,417.93 | 17.85 | 60,998.7 |
ABBOTT INDIA LTD | 1,452.29 | 46.69 | 67,806.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JAGSONPAL PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.85x |
Max industry PE | 70.81x |
Median industry PE | 25.76x |
Average industry PE | 36.89x |
You may also like the below Video Courses